IBHRE CEPS common mistakes
IBHRE CEPS · Understand the traps and how to avoid them.
Choosing the endpoint that terminates the arrhythmia rather than the one that predicts durable success - e.g., accepting acute termination of typical AVNRT during slow-pathway modification without assessing for residual slow-pathway conduction or junctional rhythm characteristics.
Candidates memorize 'ablate until it stops' from case exposure and conflate acute procedural success with the validated endpoint (loss of slow-pathway conduction, with or without residual dual physiology depending on the target).
What to do instead
For each ablation target, write a one-line 'success criterion vs. safety criterion' pair before studying indications: AVNRT = no residual slow-pathway conduction with isoproterenol/atropine challenge; typical flutter = bidirectional isthmus block confirmed by differential pacing. Test yourself by naming the confirmatory maneuver, not the arrhythmia.
Applying the same mapping modality to every ventricular tachycardia substrate, e.g., using activation mapping in a hemodynamically unstable, non-inducible patient with ischemic scar.
Activation and entrainment mapping dominate trainee teaching because they are conceptually satisfying; substrate modification (scar homogenization, core isolation, late-potential targeting) is less intuitive and gets skipped.
What to do instead
Build a decision table keyed to two axes: hemodynamic tolerance and inducibility. Stable and inducible → activation/entrainment; unstable → substrate-based mapping during sinus or paced rhythm. Practice stating which axis rules out which technique.
Treating a detected atrial high-rate episode on a device as equivalent to a clinical atrial fibrillation diagnosis and proceeding directly to anticoagulation decisions without reviewing stored electrograms, episode duration, and burden.
Candidates anchor on the device's automated label and forget that oversensing, far-field R waves, and noise generate false atrial high-rate episodes.
What to do instead
Adopt a fixed review sequence: confirm atrial signal morphology on stored EGM, quantify duration and burden, then apply the threshold from trial evidence (commonly minutes-to-hours of burden) before discussing anticoagulation. Rehearse this sequence on any atrial high-rate episode question.
Selecting the pacing mode by habit (e.g., defaulting to DDD in a patient with permanent atrial fibrillation or to VVI in a patient with sinus node dysfunction and intact AV conduction) instead of deriving it from the conduction status and chronotropic need.
Mode selection is taught as a menu of options rather than as a decision tree, so candidates pattern-match to the most familiar mode.
What to do instead
Use a three-question algorithm: is the atrium fibrillating or unusable? is AV conduction intact? is chronotropic competence needed? Answer in order - each answer eliminates specific modes. Write the algorithm once and apply it to ten vignettes.
Interpreting a prolonged HV interval or an abnormal signal-averaged ECG as an independent indication for prophylactic device therapy without integrating ejection fraction, symptom status, and the specific syndrome (e.g., bundle branch block with syncope).
Numbers feel decisive, so candidates treat a single abnormal measurement as an indication, blurring the line between a risk marker and a guideline indication.
What to do instead
For every diagnostic finding, ask 'marker or indication?' and require the answer to cite the clinical context that converts it. Keep a running list separating risk markers from actionable indications.
Mixing up the mechanistic signature of a supraventricular tachycardia - e.g., calling a response to ventricular pacing during tachycardia 'VA linking' when it is actually a septal pathway inserting near the pacing site.
Multiple phenomena (VA linking, resetting, entrainment with fusion, pathway-insertion effects) are learned as isolated definitions rather than as a differential that must be distinguished by a specific maneuver.
What to do instead
For each pacing maneuver, memorize the expected response in each tachycardia mechanism in a grid (AVNRT, orthodromic AVRT, atrial tachycardia, nodoventricular pathway). Test by predicting the response before recalling the definition.
Managing antiarrhythmic drug initiation as a routine outpatient prescription without applying the proarrhythmia and organ-toxicity monitoring specific to the agent - e.g., starting sotalol or dofetilide without QT and renal-function screening, or continuing amiodarone without thyroid, hepatic, and pulmonary surveillance.
Candidates focus on efficacy and indications and treat monitoring as nursing workflow rather than as part of the prescribing decision tested on the exam.
What to do instead
Build a drug card for each antiarrhythmic with four fields: indication, contraindication, baseline screening, and follow-up interval. Memorize the initiation thresholds (QTc, creatinine clearance, potassium) as numbers, not concepts.
Reading a device interrogation by scrolling to the summary page and accepting the programmer's automated diagnostics without reconciling them against stored EGMs, marker channel, and lead impedance trends.
Time pressure and unfamiliarity with marker-channel annotation push candidates toward the summary screen, which hides undersensing, oversensing, and lead-integrity problems.
What to do instead
Practice a fixed interrogation order: battery and lead trends, then rate histograms, then stored episodes with EGM and markers, then programmed parameters. On any device question, identify which data element would change the answer.
Recommending catheter ablation for a patient whose arrhythmia is better served by a device or drugs - e.g., pursuing VT ablation in a patient with a recent myocardial infarction and poor substrate, or ablating atrial fibrillation before addressing reversible drivers and stroke risk.
Candidates study ablation technique and indications in isolation and under-weight competing therapies, timing, and risk-benefit tradeoffs.
What to do instead
For each arrhythmia, write the ablation indication, the competing device/drug option, and the reason to defer. When a vignette appears, state the alternatives before choosing.
Ignoring periprocedural anticoagulation and vascular-access planning for ablation - e.g., not accounting for uninterrupted anticoagulation status, left atrial appendage anatomy, or access-site risk when choosing approach and sheath size.
Technical and mapping content is more heavily studied than the procedural safety framework, so anticoagulation and access planning get treated as background.
What to do instead
Create a periprocedural checklist: anticoagulation status and interruption plan, imaging for access, sedation and hemodynamic support plan, and post-procedure monitoring. Apply it to every ablation vignette regardless of the arrhythmia.